Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography

Clinical Kidney Journal

Volumn 6, Issue 6, 2013, Pages 578-583

  Filiopoulos, Vassilis ^a   Biblaki, Dimitra ^a   Lazarou, Dimitrios ^a   Chrisis, Dimitrios ^a   Fatourou, Mavra ^a   Lafoyianni, Sofia ^a   Vlassopoulos, Dimosthenis ^a  

^a AMALIA FLEMING GENERAL HOSPITAL   (Greece)

Author keywords

Acute kidney injury; Biomarkers; Computed tomography; Contrast induced nephropathy; Neutrophil gelatinase associated lipocalin

Indexed keywords

ALBUMIN; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UREA NITROGEN BLOOD LEVEL;

EID: 84890361309     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sft109     Document Type: Article

References (26)

1. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295: 2765-2779
2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936
3. Solomon R. Contrast media nephropathy: how to diagnose and how to prevent? Nephrol Dial Transplant 2007; 22: 1812-1815
4. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17: 127-132
5. Devarajan P. Neutrophil gelatinase-associated lipocalin: an emerging troponin for kidney injury. Nephrol Dial Transplant 2008; 23: 3737-3743
6. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 2010; 4: 265-280
7. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E et al. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006; 26: 287-292
8. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E et al. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography. Nephrol Dial Transplant 2007; 22: 295-296
9. Ling W, Zhaohui N, Ben H et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008; 108: c176-c181
10. Hirsch R, Dent C, Pfriem H et al. NGAL Is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007; 22: 2089-2095
11. Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and metaanalysis. Am J Kidney Dis 2009; 54: 1012-1024
12. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006; 239: 392-397
13. Rudnick MR, Goldfarb S, Tumlin J. Contrast-induced nephropathy: is the picture any clearer? Clin J Am Soc Nephrol 2008; 3: 261-262
14. Solomon R. Contrast-induced acute kidney injury: is there a risk after intravenous contrast? Clin J Am Soc Nephrol 2008; 3: 1242-1243
15. Dent CL, Ma Q, Dastrala S et al. Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; 11: R127
16. Levey AS, Bosch JP, Breyer Lewis J et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
17. Stacul F, van der Molen AJ, Reimer P et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21: 2527-2541
18. Finn WF. The clinical and renal consequences of contrastinduced nephropathy. Nephrol Dial Transplant 2006; 21 (Suppl. 1): i2-i10
19. McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010; 5: 211-219
20. Solomon RJ, Mehran R, Natarajan MK et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 2009; 4: 1162-1169
21. Mitchell AM, Jones AE, Tumlin JA et al. Incidence of contrastinduced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol. 2010; 5: 4-9
22. Weisbord SD, Mor MK, Resnick AL et al. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 2008; 3: 1274-1281
23. Barrett B, Thomsen H, Katzberg R. Nephrotoxicity of lowosmolar iopamidol vs iso-osmolar iodixanol in renally impaired patients: The IMPACT study. Invest Radiol 2006; 41: 815-821
24. Thomsen HS, Morcos SK, Erley CM et al. Investigators in the Abdominal Computed Tomography: The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008; 43: 170-178
25. Kuhn M, Chen N, Sahani DV et al. The PREDICT study: A randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. Am J Radiol 2008; 191: 151-157
26. Fassett RG, Venuthurupalli SK, Gobe GC et al. Biomarkers in chronic kidney disease: a review. Kidney Int 2011; 80: 806-821